Bispecific T cell activating antigen binding molecules
US10781257B2 · kind B2 · utility
1Cited by
30References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 18, 2018 |
| Grant date | Sep 22, 2020 |
| Priority date | — |
| Expiry date | Sep 18, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention generally relates to novel bispecific antigen binding molecules for T cell activation and re-direction to specific target cells. In addition, the present invention relates to polynucleotides encoding such bispecific antigen binding molecules, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the bispecific antigen binding molecules of the invention, and to methods of using these bispecific antigen binding molecules in the treatment of disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.